Dr. Orentas received his PhD from the Department of Pharmacology and Molecular Sciences of The Johns Hopkins University School of Medicine. While there he held post-doctoral and Research Associate positions in the Oncology Center, followed by a 12-year academic career at the Medical College of Wisconsin, where he rose to rank of Associate Professor with a primary appointment in the Department of Pediatrics, Section of Hematology-Oncology. He also held appointments in the Department of Medicine and the Department of Microbiology and Molecular Genetics.
Dr. Orentas has extensive experience in CAR T-based immunotherapy approaches to cancer therapy, and in addition to his role at CureWorks, he is a Principal Investigator in the Immunology Integration Hub of the Seattle Children’s Research Institute. Prior to his role at CureWorks, he was Scientific Director of Lentigen Technology, Inc., a Miltenyi Biotec company, and served as an Associate Scientist in the Pediatric Oncology Branch of the National Cancer Institute.